Overview
HKI-272 Ketoconazole Drug Interaction Study
Status:
Completed
Completed
Trial end date:
2006-11-01
2006-11-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
To investigate a potential pharmacokinetic drug interaction between HKI-272 and ketoconazole when co-administered.Phase:
Phase 1Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Puma Biotechnology, Inc.Treatments:
Ketoconazole
Criteria
Inclusion Criteria:- Healthy as determined by the investigator on the basis of medical history, physical
examination, clinical laboratory test results, vital signs, and 12-lead ECG.